Evaluating Hypoglossal Nerve Stimulation Outcomes in Obstructive Sleep Apnea: Impact of Predisposing Conditions in a Retrospective Cohort

Authors

  • Lina Adwer University of Nebraska Medical Center, College of Medicine, Omaha, NE 68198, USA
  • Taylor Nelson University of Nebraska Medical Center, College of Medicine, Omaha, NE 68198, USA
  • Kristy Carlson Boston Children's Hospital, Department of Ophthalmology, Boston, MA 02115, USA
  • Sarah Schmoker University of Nebraska Medical Center, Department of Otolaryngology, Omaha, NE 68198, USA
  • Kaeli Samson University of Nebraska Medical Center, Department of Biostatistics, Omaha, NE 68198, USA
  • Stanley V. Thomas CHI Health Creighton University, Department of Pulmonary Medicine, Omaha, NE 68124, USA
  • Jayme R. Dowdall University of Nebraska Medical Center, Department of Otolaryngology, Omaha, NE 68198, USA

DOI:

https://doi.org/10.5195/ijms.2025.2796

Keywords:

Hypoglossal Nerve Stimulation, Obstructive Sleep Apnea, Patient Outcomes, Comorbid Conditions, Sleep-Related Comorbidities, Polysomnography, CPAP Intolerance, Personalized Treatment, Clinical Benefits, Predictive Factors

Abstract

Background: This retrospective study aimed to analyze treatment outcomes for patients receiving a hypoglossal nerve stimulation (HNS) device for obstructive sleep apnea (OSA). Methods: Chart reviews were conducted for HNS patients who underwent a post-implantation polysomnography (PSG) (typically performed approximately 2 months after device activation) to assess therapeutic response and optimize stimulation settings. Patients were categorized into “green (GP)” (optimal response: AHI <15, ≥4 hours/night device use, and subjective benefit) and “yellow (YP)” (suboptimal response: failure to meet one or more of these criteria) response pathways. Results: Out of 111 patients assessed, 27 patients met pathway categorization criteria. 12 of those were classified in green and 15 in yellow. Median age and BMI were 63.9 years and 28.7 kg/m², respectively, with a balanced sex assigned at birth distribution. HNS treatment reduced median AHI by 85.6% (from 34.7 to 5.0) for the green pathway (GP), and by 87.4% (from 39.6 to 5.0) for the yellow pathway (YP).  Patients who had at least one sleep-related comorbidity were more likely to be in the yellow pathway (p < .001). Comorbidities such as depression and insomnia were significantly associated with suboptimal treatment response (yellow pathway) (p = .003 and p = .02, respectively). Conclusions: This study emphasizes the significance of sleep-related comorbidities as a strong predictor of patient outcomes. More efficient utilization of resources may be achieved by considering comorbid conditions prior to HNS implantation. Given the small sample size and retrospective single-institution design, these findings should be interpreted with caution and may not be generalizable to broader populations.

Metrics

Metrics Loading ...

References

Ghavami T, Kazeminia M, Ahmadi N, Rajati F. Global Prevalence of Obstructive Sleep Apnea in the Elderly and Related Factors: A Systematic Review and Meta-Analysis Study. J Perianesth Nurs. 2023;38(6):865-875.

Lin HS, Prasad AS, Pan CJ, Rowley JA. Factors associated with noncompliance to treatment with positive airway pressure. Arch Otolaryngol Head Neck Surg. 2007;133(1):69-72.

Qiao M, Xie Y, Wolff A, Kwon J. Long term adherence to continuous positive Airway pressure in mild obstructive sleep apnea. BMC Pulm Med. 2023;23(1):320.

Schwartz AR, Jacobowitz O, Eisele DW, et al. Targeted Hypoglossal Nerve Stimulation for Patients with Obstructive Sleep Apnea: A Randomized Clinical Trial [published correction appears in JAMA Otolaryngol Head Neck Surg. 2024 Jun 1;150(6):530. doi: 10.1001/jamaoto.2024.0412]. JAMA Otolaryngol Head Neck Surg. 2023;149(6):512-520.

Strollo PJ Jr, Rogers RM. Obstructive sleep apnea. N Engl J Med. 1996;334(2):99-104.

Sawyer AM, Gooneratne NS, Marcus CL, Ofer D, Richards KC, Weaver TE. A systematic review of CPAP adherence across age groups: clinical and empiric insights for developing CPAP adherence interventions. Sleep Med Rev. 2011;15(6):343-356.

Baillieul S, Dekkers M, Brill AK, et al. Sleep apnoea and ischaemic stroke: current knowledge and future directions. Lancet Neurol. 2022;21(1):78-88.

Kirsch DB. Obstructive Sleep Apnea. Continuum (Minneap Minn). 2020;26(4):908-928.

Bouzerda A. Risque cardiovasculaire et syndrome d’apnées obstructives du sommeil [Cardiovascular risk and obstructive sleep apnea]. Pan Afr Med J. 2018;29:47.

Hobzova M, Prasko J, Vanek J, et al. Depression and obstructive sleep apnea. Neuro Endocrinol Lett. 2017;38(5):343-352.

Malhotra A. Hypoglossal-nerve stimulation for obstructive sleep apnea. N Engl J Med. 2014;370(2):170-171.

Tukanov E, Van Loo D, Dieltjens M, Verbraecken J, Vanderveken OM, Op de Beeck S. Baseline Characteristics Associated with Hypoglossal Nerve Stimulation Treatment Outcomes in Patients with Obstructive Sleep Apnea: A Systematic Review. Life (Basel). 2024;14(9):1129. Published 2024 Sep 7.

Soose, RJ, Faber, K, Greenberg H, Boon M, Woodson T, Strollo P. (2021). Post-implant care pathway: lessons learned and recommendations after 5 years of clinical implementation of hypoglossal nerve stimulation therapy. Sleep, 44(Suppl 1): S4–S10.

Steffen A, Baptista P, Ebner EM, Jeschke S, König IR, Bruchhage KL. Insomnia affects patient-reported outcome in sleep apnea treated with hypoglossal nerve stimulation. Laryngoscope Investigative Otolaryngology. 2022;7(3):877–884.

Pordzik J, Ludwig K, Seifen C, Huppertz T, Bahr-Hamm K, Matthias C, Gouveris H. Insomnia in Patients Undergoing Hypoglossal Nerve Stimulation Therapy for Obstructive Sleep Apnea. Biology. 2023;12(1):98.

The table compares participants in the Green (n = 12) and Yellow (n = 15) pathways. Sex assigned at birth was evenly distributed between groups (p = 1.00). A higher proportion of smokers was observed in the Yellow Pathway (71.4%) compared to the Green Pathway (28.6%), with a near-significant difference (p = 0.08).

Published

2025-06-19

How to Cite

Adwer, L., Nelson, T., Carlson, K., Schmoker , S. S., Samson, K., Thomas, S. V., & Dowdall, J. R. (2025). Evaluating Hypoglossal Nerve Stimulation Outcomes in Obstructive Sleep Apnea: Impact of Predisposing Conditions in a Retrospective Cohort. International Journal of Medical Students, 13(2), 182–186. https://doi.org/10.5195/ijms.2025.2796

Issue

Section

Short Communication

Categories